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Interleukin-8 (IL-8) is a neutrophilic chemotactic factor which may have a prominent role in the attraction of 
neutrophils to the lung in idiopathic pulmonary fibrosis (IPF). The objective of this study was to investigate the 
usefulness of IL-8 expression in bronchoalveolar lavage (BAL) cells in the evaluation of alveolitis in IPF. We 
analysed the BAL cell expression of IL-8 by immunocytochemistry in 19 patients with IPF (six smokers, three 
ex-smokers and ten non-smokers) and in a control group composed of 14 individuals (six smokers, eight 
non-smokers). In IPF, BAL was performed on both the pulmonary lobe with the most extensive involvement and 
the one less extensively involved on high-resolution computed tomography (HRCT) scans. The percentages and 
absolute numbers of BAL IL-8’ macrophages from lobes with the most extensive HRCT scan involvement (36 f 6% 
and (6 f- 2 x lo4 ml - ‘) (SE) and from those less extensively involved [26% f 4% and (6 f 1) x 10” ml- ‘1 were 
significantly higher with respect to both those from healthy smokers [17% f 6% and (7 f 4) x lo4 ml- ‘1 and those 
from non-smokers [2% + 1% and (1 f 0.3) x lo4 ml ~ ‘1 (P=O.OOS and P=O.OOl, respectively), without differences 
between the two lobes. In contrast, both the proportions and the absolute numbers of BAL neutrophils in IPF were 
significantly higher in lobes with the most extensively involved HRCT scan in comparison with lobes with the least 
extensive involvement [13% + 3%, (3 f 1) x lo4 ml - ’ KY. 8% f 2%, (1 * 0.3) x lo4 ml ~ I, P=O.O5]. Moreover, the 
numbers of BAL neutrophils, but not those of IL-8’ macrophages, correlated with the extent of total pulmonary 
HRCT scan abnormalities in the most involved lobe (r=0.64, P=O.O4). A correlation between neutrophils and IL-8’ 
cells was not observed. The results of this study suggest that, in IPF, BAL neutrophilia offers a better description of 
the disease inflammatory process than the expression of IL-8 in BAL cells. 
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Introduction 
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung 
disease of unknown aetiology characterized by a chronic 
inflammatory process and progressive fibrosis of the 
alveolar structures and interstitium. Bronchoalveolar 
lavage (BAL) from patients with idiopathic pulmonary 
fibrosis shows an increased number of neutrophils (1) and 
the chronic presence of these cells in the alveolar structures 
probably plays a prominent role in the parenchymal injury 
seen in this disorder. It has been shown that several 
neutrophil chemoattractants may be responsible for the 
accumulation of neutrophils in the lung (2). Interleukin-8 
(IL-g) is a peptide of the C-X-C chemokine family with a 
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significant neutrophil chemotactic activity. It also has been 
suggested that this cytokine may have an important role in 
the attraction of neutrophils to the lung in IPF (3,4). 
Several studies have demonstrated that the constitutive 
expression of IL-8 mRNA and cell-associated protein 
in alveolar macrophages is significantly elevated in 
patients with IPF and that alveolar macrophages are the 
major cell source of IL-8 in this condition (5-9). Although 
some studies (S-7) have shown that the level of IL-8 
expression correlates with the proportion of BAL neu- 
trophils in IPF, the role of IL-8 as a clinical marker of 
disease inflammatory activity has not been completely 
defined as yet. In a previous study, we have demonstrated 
that in patients with IPF the BAL cell populations in the 
different pulmonary lobes are not uniform and appear to be 
related to the extent of the high-resolution computed 
tomography (HRCT) scan abnormalities present in the 
lavaged lobe (10). In order to determine further the 
usefulness of IL-S in the evaluation of the presence of 
alveolitis in IPF, we have investigated the relationship 
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between IL-8 expression on BAL cells and BAL cell 
analysis and HRCT findings. 
Methods 
POPULATION STUDIED 
Control Group 
The control group was composed of 14 individuals with no 
evidence of diffuse respiratory disease, normal pulmonary 
function tests and absence of respiratory infections in the 
preceding 3 months. Fibre-optic bronchoscopy was per- 
formed in view of a single episode of haemoptysis with 
normal chest X-ray, isolated pulmonary node or suspicion 
of upper airway disease. In all patients, bronchoscopy was 
macroscopically normal with negative microbiological and 
cytological analysis of bronchial washings. The control 
group was divided into two subpopulations: the non- 
smoking group was composed of eight subjects (five men. 
age 45 & 5.8 years) (SE) and the smoking group consisted 
of six subjects (four men, age 45 i- 6 years) who had 
been smoking 39 f 9 standard packs yr ~ ’ (range, 5570 
packs yr -~ ‘). 
Idiopathic Pulmonury Fibrosis 
The population studied was composed of 19 untreated 
patients (15 men, age 67 f 2 years) with IPF. Six of them 
were smokers (39 f 8 packs yr ~ ‘, range 15570 packs yr - ‘), 
three stopped smoking at least 5 yr before entry into the 
study and the remaining ten patients had never smoked. All 
patients had cough and/or dyspnoea with a duration of 
symptoms of 10 f 3 months (range, l-36 months). Eight 
patients had finger clubbing and 16 bilateral widespread 
crackles. Chest X-my showed persistent bilateral interstitial 
infiltrates in all the patients. The diagnosis of IPF was 
established by open lung biopsy in seven patients. In the 
remaining 12 patients, two conditions were required to 
establish the diagnosis: (1) to fulfil the clinical criteria 
described by Turner-Warwick et ~1. as we previously used 
(1 l-13) and (2) to have findings compatible with IPF on 
HRCT scan (14,15). Pulmonary function tests were per- 
formed as has been previously described, using the refer- 
ence values from our own laboratory (16,17). None of the 
patients had associated collagen vascular disease. The study 
was performed as part of the current diagnostic assessment 
and outpatient monitoring for interstitial lung diseases in 
our department (12,13). BAL differential cell counts and 
HRCT scan findings of some of the patients included in this 
study have been previously reported (10). All subjects were 
informed of the characteristics and nature of the procedures 
to be performed and all gave full informed written consent. 
The study was approved by the Ethics Committee of the 
Hospital Clinic. 
HIGH-RESOLUTION COMPUTED 
TOMOGRAPHY SCAN 
Computed tomography scans were performed in either a 
Somaton HiQ or a Somaton Plus scanner (Siemens, 
Erlangem, Germany), as has been previously described (10). 
HRCT scans were obtained at six predetermined levels: the 
great vessels, the aortic arch, the tracheal carina, the 
pulmonary hilae, the pulmonary venous confluence and 
1 cm above the right diaphragm. The scans were performed 
with a l-2 mm section thickness and l-2 s scanning time 
during breath-holding at end-inspiration. 
Two radiologists examined the HRCTs without knowl- 
edge of clinical, functional and radiographic findings. The 
overall extent of lobar abnormalities was scored in the six 
levels in which HRCT scans were obtained, the percentage 
of lung parenchyma affected being calculated. Then. a 
semiquantitative analysis of the relative proportion (to 
within 10%) of both the ground glass and the reticular 
patterns was performed. By consensus agreement, two 
pulmonary lobes were selected: the one with the most 
extensive involvement and that with the least extensive 
involvement (10). 
BRONCHOALVEOLAR LAVAGE 
BAL was performed at random on both the pulmonary 
lobe with the most extensive involvement and the one less 
extensively involved on HRCT scan. In the control group, 
BAL was performed only on the middle lobe or the lingula. 
Total cell count, cell viability and differential cell counts 
were determined as previously described (10,18). Immuno- 
cytochemical analysis of IL-S on BAL cells was performed 
using the immunoalkaline phosphatase method (19). Cyto- 
centrifuge smears were fixed in acetone and incubated in 
foetal calf serum at 25% to block the non-specific binding 
sites. Cell preparations were sequentially incubated with 
rabbit anti-human IL-8 antibodies (ICN Biomedicals, CA, 
USA) at a dilution of l/l00 for 16 h at 4°C mouse 
anti-rabbit immunoglobulins (Dakopatts, Denmark), 
rabbit anti-mouse immunoglobulins (Dakopatts, Denmark) 
and alkaline phosphatase anti-alkaline phosphatase 
complexes (Dakopatts, Denmark). The development of the 
reaction was performed using an alkaline phosphatase 
substrate. Slides were counterstained with Mayer’s haema- 
toxylin and mounted in an aqueous medium. The negative 
control of the immunocytochemical reaction was carried 
out by incubating the cell smears with all reagents except 
the anti-IL-8 antibody and replacing the anti-human IL-8 
antibody with normal rabbit serum. The IL-E+ cells were 
red stained and easily distinguished from the negative cells. 
All quantifications of stained cells were done by two 
independent investigators using light microscopy (1000 x ) 
to determine the number of stained cells. 
Pulmonary function tests, HRCTs and BAL were 
performed at the time of the clinical diagnosis. The 
time taken for the three procedures was within less than 
1 week. 
STATISTICAL ANALYSIS 
Results are expressed as mean f SE. Wilcoxon’s test was 
used for comparison of paired data and Mann-Whitney’s 
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TABLE 1. Pulmonary function tests of patients with idiopathic pulmonary fibrosis 
Actual values Predicted (%) 
FEV, (1) 1.9 * 0.1 (0.0-3.4) 73 f 4.0 (46-97) 
FVC (1) 2.4 zt 0.2 (1.14.4) 63 + 3.5 (39-93) 
FEV,/FVC 84 zt 1 (70-99) 
TLC (1) 4.5 f 0.3 (3.3-6.9) 74 z?z 5 (44-107) 
DLCO (ml min - i mmHg - ‘) 13 zt 1.2 (619) 54 z!z 5 (26-82) 
KC0 (ml min-’ mmHg-’ ml-‘) 4 f 0.3 (2-6) 77 f 7 (51-131) 
PaO, (kPa) 9.6 f 0.5 (4.1-12) 
AaPO, (kPa) 4.5 + 5 (2.3-10) 
Ranges of values in parentheses. 
TABLE 2. High-resolution computed tomography scan scores in lobes with maximal and minimal 
involvement 
Maximal 
involvement 
Ground glass 29 z!z 6.5 (o-90) 
Reticular 37 * 1’1 (O-70) 
Total 66 f 6 (20-99) 
Ranges of values in parentheses. 
Minimal 
involvement 
5 zk 2.2 (O-30) 
22 Lt 3 (O-50) 
27 + 4 (10-60) 
P values 
0.001 
0.000 1 
0~0001 
test for unpaired data. Spearman’s correlation coefficients 
were used when appropriate for correlation analysis. The 
influence of smoking in IL-8 expression was tested by a 
two-way analysis of variance (ANOVA). Statistical signifi- 
cance was established when the P value was equal to or 
lower than 0.05. 
Results 
PULMONARY FUNCTION TESTS (TABLE 1) 
One patient was not able to undergo the pulmonary func- 
tion tests. DLCO was not performed in six patients because 
of severe reduction of lung volumes and/or lack of 
co-operation. All patients had a moderate to severe restric- 
tive ventilatory impairment and eight patients a TLC below 
80% predicted. DLCO was below the lower limit of refer- 
ence (80% predicted) and 11 out of 12 patients in whom it 
was measured and KC0 was below 80% predicted in seven 
cases. Arterial blood gases were measured in all but one 
patient. Arterial hypoxaemia (PaO, < 10.7 kPa) was present 
in 15 patients and AaPO, was increased (>2.7 kPa) in 15. 
HIGH-RESOLUTION COMPUTED 
TOMOGRAPHY SCAN SCORING ANALYSIS 
In Table 2, the scoring analysis of HRCT scans in the 
lobes with both maximal and minimal involvement is 
represented. There was a significant difference in the ground 
glass and reticular scores (P=O.OOl and P=O.OOOl, respect- 
ively) as well as in the total score between both lobes 
(P=o~ooo1). 
BRONCHOALVEOLAR LAVAGE FLUID 
ANALYSIS 
In the control group, the total cell counts and the absolute 
numbers of macrophages were higher in smokers with 
respect to non-smokers, although there were no differences 
in differential cell counts (Table 3). In patients with IPF 
(Table 4), the percentages and absolute numbers of neu- 
trophils and eosinophils were significantly elevated in BAL 
from both the lobe with the most extensive involvement and 
that with the least extensive involvement on HRCT scans, 
with respect to the control group. The comparisons 
of the characteristics of BAL in the two lavaged lobes 
showed that both the percentages and absolute numbers of 
neutrophils and those of eosinophils were significantly 
higher in BAL performed on areas with the most 
extensive HRCT scan involvement (P=O.O5 and PzO.02, 
respectively) (Table 4). 
In the control group, immunocytochemical analysis of 
cytocentrifuge BAL cell smears showed that both the 
percentages and the absolute numbers of IL-8-positive 
alveolar macrophages had a tendency to be higher in 
healthy smokers [17% & 6% and (7 f 4) x lo4 ml - ‘1 in 
comparison with non-smokers [2% l 1% and 
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TABLE 3. Bronchoalveolar lavage characteristics of the control group 
Smokers Non-smokers 
(n=6) (n=S) P values 
Volume recovered (ml) 58 i 7 (35-83) 45 f 7 (24-81) NS 
Total cells ( x lo4 ml ‘) 54f 11 (5-81) 24 L!Z 4 (645) 0.05 
Cell viability (%) 84 xt 4 (71-95) 75 zk 5 (50-95) NS 
Macrophages (%) 96 i 1 (94-98) 94 It 1 (91-99) NS 
Macrophages ( x lo4 ml ~ ‘) 52 i 10 (1476) 23 f 4 (641) 0.02 
Lymphocytes (%) 3 f 1 (226) 4f 1 (l-8) NS 
Lymphocytes ( x lo4 ml ~ ‘) 2 f 1 (0.335) 1 f 0.5 (0.14) NS 
Neutrophils (%I) 0.3 f 0.1 (O-l) 1 f 1 (O-3) NS 
Neutrophils ( x lo4 ml - ‘) 0.1 zt 0.1 (O-0.3) 0.3 f 0.1 (O-0.9) NS 
Macrophages IL-8’ (%) 17 + 6 (O-36) 2 i 1 (O-6) 0.06 
Macrophages IL-8’ ( x lo4 ml - ‘) 7&4 (O-21) 1 i 0.3 (O-2) 0.06 
Ranges of values in parentheses. 
TABLE 4. Characteristics of bronchoalveolar lavage performed on both the pulmonary lobe with the 
most extensive involvement and the one least extensively involved on high-resolution computed 
tomography scan in patients with idiopathic pulmonary fibrosis 
Maximal 
involvement 
Minimal 
involvement P values 
Volume recovered (ml) 
Total cells ( x lo4 mll ‘) 
Cell viability (%) 
Macrophages (%) 
Macrophages ( x lo4 ml ~ ‘) 
Lymphocytes (%) 
Lymphocytes ( x lo4 ml ~ ‘) 
Neutrophils (%) 
Neutrophils ( x lo4 ml ~ ‘) 
Eosinophils (%) 
Eosinophils ( x lo4 ml ~ ‘) 
Macrophages IL-8+ (%) 
Macrophages IL-8+ ( x lo4 ml- ‘) 
31 * 2 (1745) 32 f 2 (1648) NS 
22 f 3 (5-51) 23 f 5 (5-77) NS 
73 f 3 (44-99) 71 4~ 3 (47-96) NS 
77 f 3 (5696) 83 f 3 (43-96) NS 
16 i 2 (4439) 19 f 4 (473) NS 
5 zt 1 (l-14) 6 f 2 (o-32) NS 
1 f 0.5 (0.1-7) 1 f 0.5 (O-7) NS 
13 f 3 (O-34) 8 f 2 (O-26) 0.05 
3 f 1 (O-15) 1 f 0.3 (O-5) 0.05 
5 f 1 (O-19) 2 f 1 (O-12) 0.02 
1 i 0.3 (O-4) 0.5 f 0.2 (O-5) 0.02 
36 f 6 (2-74) 26 f 4 (O-60) NS 
6 i 2 (0.2.-28) 6 i 1 (O-20) NS 
Ranges of values in parentheses. 
(1 i 0.3) x lo4 mll ‘) (P=O.O6) (Fig. 1). While in non- 
smokers only a few macrophages (O-6%) expressed IL-8, 
three smokers had an elevated percentage of IL-8-positive 
macrophages (28%, 29% and 36%, respectively). No 
correlation was shown between the amount of 
pack-years smoked and the percentage of IL-8’ macro- 
phages. Moreover, a correlation between neutrophils 
and IL-8’ macrophages was not found. In patients 
with IPF, the percentages and absolute numbers of BAL 
IL-8’ macrophages from lobes with the maximal and 
minimal involvement according to HRCT scans 
[36%* 6% and (6 f 2) x 104mll vs. 26%*4% and 
(6~t 1) x 104mll’, respectively] were significantly greater 
compared with both healthy smokers and non-smokers 
(Table 4, Fig. 1). However, there were no differences 
between the numbers of IL-8’ macrophages in the 
BAL performed on areas with maximal HRCT involvement 
and the BAL from areas with minimal involvement 
(Table 4, Fig. 1). In IPF patients, the numbers of macro- 
phages expressing IL-8 were not different in smokers in 
comparison with ex-smokers and non-smokers. Differences 
in IL-8 expression between the control group and IPF 
patients were not influenced by smoking (P=O.68). A 
correlation between BAL neutrophils and IL-8’ macro- 
phages was not observed. We found a correlation 
between both the percentages and absolute numbers of 
BAL neutrophils and the extent of total pulmonary 
HRCT scan abnormalities in the most involved lobe 
(r=O.64, P=O.Ol, and v=O.6, P=O.O05, respectively), 
not present with the other cell types. In contrast, the 
numbers of IL-8’ macrophages did not correlate with 
HRCT findings. 
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FIG. 1. Percentage of BAL IL-8+ cells in the 
subpopulations of the control group (nonsm, non- 
smokers; sm, smokers) and in patients with idiopathic 
pulmonary fibrosis (IPF) (min, pulmonary lobes with 
the least extensive involvement on HRCT scan; max, 
pulmonary lobes most extensively involved on HRCT 
scan). 
Discussion 
The novel findings of our study is that we investigated the 
usefulness of IL-8 expression in the evaluation of alveolitis 
in IPF, by comparing the results of IL-S expression with 
both BAL cellular analysis and HRCT scan findings. Dif- 
ferent studies have demonstrated that the appearance of 
HRCT scans predicts histological patterns made evident in 
open lung biopsy. Both reticular and honeycombing 
patterns correlate with the presence of fibrosis whereas a 
ground glass pattern identifies zones of alveolar and inter- 
stitial inflammation (20). In a previous study, we have 
demonstrated that the percentage of both neutrophils and 
eosinophils in BAL fluid is significantly higher in the most 
involved areas of the lung parenchyma determined by 
HRCT scan and that the percentage of neutrophils corre- 
lates with the extent of both whole HRCT scan abnormali- 
ties and ground glass pattern in the lavaged lobe (10). The 
findings of the present study confirm and further extend our 
previous results, suggesting that computed-tomography- 
guided BAL may improve the assessment of alveolitis in 
IPF. However, we did not find differences between the 
percentage of IL-8+ macrophages in the BAL performed on 
areas with the most extensive involvement and that from 
areas less extensively involved on HRCT scan. In addition, 
a correlation between the number of IL-8’ macrophages 
and both the percentage of BAL neutrophils and HRCT 
findings was not shown. Our results are therefore at vari- 
ance with those of other studies (557) in which the level of 
BAL cell IL-8 expression correlated with the proportion of 
neutrophils. These differences and the lack of correlation 
between BAL IL-8 expression and HRCT score may be 
explained by the different methods used to determine the 
expression of IL-8. Car& et al. (5) and Southcott et al. (7) 
used the polymerase chain reaction and ELISA to assess the 
presence of IL-8, methods probably more quantitative than 
immunocytochemistry. However, the sensitivity of immu- 
nocytochemistry may be higher than that of other 
antibody-based techniques (e.g. ELISA) because the anti- 
gen may be highly concentrated in a localized area, such as 
within a cell or within a cell membrane (21). On the other 
hand, there is evidence that in IPF other chemotactic 
factors may contribute to the accumulation of neutrophils 
in the lung parenchyma, as shown by Car and coworkers 
(22). Moreover, it has been shown that several neutrophil 
chemotactic factors, such as leukotriene B, and (X-derived 
neutrophil chemotactic factor, are present in BAL from 
patients with IPF (2,23). 
This study has confirmed that the expression of IL-8 in 
BAL cells is increased in patients with IPF in comparison 
with healthy smokers and non-smokers. Several former 
studies have demonstrated that both the expression of IL-8 
in BAL cells and IL-8 levels in BAL supernatants are 
increased in patients with IPF (S-8,22). In the present 
study, the immunocytochemical analysis of BAL cells 
showed that IL-8 was expressed by alveolar macrophages 
but not the other cell types. Although other cells, such as 
bronchial epithelial cells, fibroblasts and neutrophils, are 
also able to synthesize IL-8, Strieter et al. (8) demonstrated 
that airspace macrophages are the main source of this 
cytokine in IPF. Similar results have been obtained by 
Southcott et al. (7) using in situ hybridization studies in 
lung biopsies from patients with IPF. All in all, these 
findings suggest that elevated levels of IL-8 are compart- 
mentalized to the alveolar space and not to the interstitium 
of the lung in IPF. 
It is interesting to note that the immunocytochemical 
analysis showed that the number of BAL IL-8’ macro- 
phages had a tendency to be higher in healthy smokers in 
comparison with non-smokers. Our findings are at variance 
with those of other studies (57) which did not find any 
significant difference in IL-8 expression between healthy 
smokers and non-smokers. In contrast, other authors have 
demonstrated that an elevated concentration of IL-8 in 
BAL fluid as well as an increased expression of IL-8 in BAL 
macrophages may be found in healthy smokers with normal 
pulmonary function tests (24). These findings can be 
explained because particulates present in cigarette smoke 
may stimulate alveolar macrophages both in viva and in 
vitro to exhibit a neutrophil chemotactic activity probably 
related to IL-8 (25). However, the results of the present 
study show that smoking does not play a role in influencing 
the differences observed in IL-8 expression between con- 
trols and IPF patients. The role of smoking in the patho- 
genesis of IPF has been widely studied. It has been shown 
that a history of smoking is associated with an increased 
risk for the development of IPF (26). Moreover, Schwartz 
et al. (27) have suggested that smoking may be a determi- 
nant of the increased numbers of BAL neutrophils in these 
patients. Probably, the lack of influence of smoking on 
IL-8’ macrophages in IPF found in our study may be 
explained by the small number of current smokers in the 
IPF group (six patients). 
In conclusion, the results of our study confirm that 
alveolar macrophages of patients with IPF constitutively 
express IL-8. On the other hand, the lack of correlation 
between IL-8 expression in BAL cells and both HRCT 
findings and BAL differential cell counts suggests that the 
presence of neutrophilia offers a better description of the 
disease inflammatory process than the expression of IL-8 in 
BAL cells. 
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